2m 2m 2m 2m 2m 2m 2m
REDHILL BIO SP ADS (RDHL)
NASDAQ
$0.97-$0.04 (-3.76%)
Price as of Jun 03, 2026 6:56 PM EDT- $5.2MMarket Cap
- -45.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
REDHILL BIO SP ADS (RDHL)
$0.97-$0.04 (-3.76%)
RDHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.01 | ||
Change | +$0.01 (+1.00%) | ||
Open | $1.02 | ||
High | $1.03 | ||
Low | $0.98 | ||
Previous Close | $1.00 | ||
Volume | 172,717 | ||
30-Day Average Volume | 107,683 | ||
1-Week Change | 0.00% | ||
1-Month Change | -6.91% | ||
1-Year Change | -45.70% | ||
3-Year Change | -98.10% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $25.3M | ||
Market Cap | $5.2M | ||
Enterprise Value | $1.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/20/2024 | ||
Earnings & Revenue